Amsterdam, the Netherlands, 24 November 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Curetis, a private German molecular diagnostic company developing and marketing reliable, fast and cost-effective products for diagnosing severe infectious diseases. A PDF version of Curetis’ press release can be found here.
For more information, please contact:
Dr. Rudy Dekeyser, Managing Partner LSP HEF
Tel: +31 (0)20 664 55 00
Dr. Jörg Neermann, Partner LSP IV
Tel: +49 (0) 89 330 666-0